We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Radiation-Free Approach Images Molecules in Brain

By MedImaging International staff writers
Posted on 22 Dec 2016
Print article
Image: CGRP-based sensors dilate blood vessels in the brain to make them visible on MRI (Photo courtesy of Alan Jasanoff / MIT).
Image: CGRP-based sensors dilate blood vessels in the brain to make them visible on MRI (Photo courtesy of Alan Jasanoff / MIT).
A new study describes how protein-based sensors can cause blood vessels to dilate near their targets, allowing them to be detected by magnetic resonance imaging (MRI).

Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), the probes are based on a modified calcitonin gene-related peptide (CGRP), which is active primarily during migraines or inflammation. The novel CGRP-related peptide is used to artificially activate vasculature dilation at nanomolar concentrations, thus enhancing an endogenous multimodal tissue contrast which can then be readily measured by optical and MRI scans in order to determine where the proteases were detected.

In order to direct the CGRP-related peptide to their targets, they have been engineered so that they are trapped within a protein enclosure that keeps them from interacting with blood vessels. But when the peptides encounter proteases in the brain, the enclosures are disrupted, releasing CGRP, which causes nearby blood vessels to dilate. The researchers are now working on adapting the design to monitor neurotransmitters by modifying the enclosures surrounding the CGRP so that they can be removed by interaction with a specific neurotransmitter. The study was published on December 2, 2016, in Nature Communications.

“Currently the gold standard approach to imaging molecules in the brain is to tag them with radioactive probes. However, these probes offer low resolution and they can't easily be used to watch dynamic events,” said lead author professor of biological engineering Alan Jasanoff, PhD. “This is an idea that enables us to detect molecules that are in the brain at biologically low levels, and to do that with these imaging agents or contrast agents that can ultimately be used in humans.”

The vasculature is one of the most potent endogenous contrast sources available to imaging modalities. Vascular hemodynamic changes can be evoked by a variety of chemical species, many of which act at nanomolar concentrations. The changes in blood volume, flow, or oxygenation are robustly detectable by MRI, optical, and ultrasound-based noninvasive imaging, as well as by positron emission tomography (PET), single photon computed tomography, and X-ray imaging with intravascular tracers.

Related Links:
Massachusetts Institute of Technology

Radiation Therapy Treatment Software Application
Elekta ONE
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
New
Digital Radiography System
DigiEye 330

Print article

Channels

Ultrasound

view channel
Image: The addition of POC ultrasound can enhance first trimester obstetrical care (Photo courtesy of 123RF)

POC Ultrasound Enhances Early Pregnancy Care and Cuts Emergency Visits

A new study has found that implementing point-of-care ultrasounds (POCUS) in clinics to assess the viability and gestational age of pregnancies in the first trimester improved care for pregnant patients... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–portron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.